Renue Wellness
Renue Wellness is a multi-location mental health practice offering IV ketamine infusions, FDA-approved Spravato, ketamine-assisted psychotherapy, and TMS therapy for treatment-resistant depression, anxiety, PTSD, OCD, and chronic pain across clinics in New York, New Jersey, and Florida.
- Company typePrivate
- Founded2017
- HeadquartersNew Hyde Park, New York, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Renue Wellness does
Renue Wellness is a privately held, physician-led mental health practice specializing in ketamine-based treatments for patients who have not responded to traditional antidepressants or psychotherapy. Founded in 2017 in New Hyde Park, New York, the practice operates three clinic locations — its flagship in New Hyde Park, a second site in Paramus, New Jersey (opened 2024), and a third in Crestview, Florida (opened 2025–2026) — serving Nassau County, Northern New Jersey, and Florida's Emerald Coast. The clinical team is led by Medical Director Dr. Jerry Frenkel (board-certified in Emergency Medicine) and includes a board-certified psychiatrist, a Rising Star NY Times Top Doctors designee, and multiple psychiatric-mental health nurse practitioners.
The core service line is built around three ketamine-based modalities: (1) IV ketamine infusion therapy, administered off-label in 40–60 minute supervised sessions targeting NMDA receptors and BDNF-driven neuroplasticity; (2) Spravato (esketamine) nasal spray, the only FDA-approved ketamine derivative for treatment-resistant depression, dispensed under the REMS program; and (3) Ketamine-Assisted Psychotherapy (KAP), which integrates ketamine dosing with guided talk therapy. Transcranial Magnetic Stimulation (TMS) is offered as an adjunct non-medication modality at the Crestview, FL site. Indication coverage spans treatment-resistant depression, anxiety disorders, PTSD, OCD, suicidal ideation, postpartum depression, chronic pain syndromes, and substance abuse.
The business model is hybrid: Spravato and TMS are billed through major commercial insurers and Medicare/Medicaid (with stated coverage from Aetna, Humana, UnitedHealthcare, Cigna, Fidelis, Horizon NJ Health, and others), while IV ketamine is largely self-pay, with patient financing through CareCredit and Advanced Care. Go-to-market is direct-to-consumer — patients discover the practice via organic search, social media (Facebook, Instagram, LinkedIn), and a formal provider referral program — combined with a published partnership initiative seeking clinic acquisitions, mergers, and co-branded affiliations for inorganic expansion. The practice has LegitScript certification and maintains HIPAA-compliant operations.
Renue Wellness firmographics
Firmographics- Name
- Renue Wellness
- Legal name
- Renue Wellness
- Website
- https://renuewellness.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Renue Wellness is a multi-location mental health practice offering IV ketamine infusions, FDA-approved Spravato, ketamine-assisted psychotherapy, and TMS therapy for treatment-resistant depression, anxiety, PTSD, OCD, and chronic pain across clinics in New York, New Jersey, and Florida.
- Ownership category
- akta.pro rank
Renue Wellness industry classification
Industry- Product category
- Mental Health Treatment Services
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
- akta.pro primary industry
- Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)
Keywords
Where Renue Wellness is headquartered
LocationHeadquarters
- HQ city
- New Hyde Park, New York
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Renue Wellness business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Revenue model
- IV Ketamine Infusion Therapy: Fee-for-service IV ketamine treatments. Patients pay out-of-pocket as IV ketamine is typically not covered by insurance. Financing options available through CareCredit and Advanced Care financing programs.
- Spravato (Esketamine) Treatment: FDA-approved esketamine nasal spray treatment covered by most major insurance providers including commercial plans and Medicare. Revenue collected through insurance reimbursements and patient copays. Covered by Aetna, Humana, United Healthcare, Medicaid, Medicare, WellCare, Cigna, Fidelis Care, Horizon NJ Health, Jefferson Health Plans.
- TMS Therapy: Transcranial Magnetic Stimulation treatments available at Crestview, FL location. Typically covered by insurance for eligible patients with depression diagnosis.
- Ketamine-Assisted Psychotherapy: Psychotherapy sessions combined with ketamine treatment for integrated mental health care.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | IV Ketamine Infusion - Self-pay treatment |
| Subscription | Monthly | Spravato Treatment - Insurance-covered |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Renue Wellness product offering
Product offeringCore offering
Renue Wellness is a multi-location mental health practice delivering medically supervised IV ketamine infusion therapy, FDA-approved Spravato (esketamine) treatment, Ketamine-Assisted Psychotherapy, and TMS therapy to adults with treatment-resistant depression, anxiety, PTSD, OCD, suicidal ideation, postpartum depression, and chronic pain. Services are delivered through clinics in New Hyde Park NY, Paramus NJ, and Crestview FL, supported by provider referrals and insurance billing.
Product overview
Renue Wellness is a multi-location mental health practice offering ketamine-based treatments and related therapies. The core offerings include IV Ketamine Infusion Therapy, Spravato (esketamine) Treatment, and Ketamine-Assisted Psychotherapy as the primary treatment modalities, with TMS Therapy available at select locations. These treatments target treatment-resistant depression, anxiety, PTSD, OCD, and related mental health conditions. The practice operates flagship clinics in New Hyde Park, NY (main location), Paramus, NJ, and Crestview, FL, serving Long Island, Queens, and surrounding communities.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Many patients experience relief within hours to days of treatment (vs weeks for traditional antidepressants)
- +2 more outcomes
Companies that use Renue Wellness
Customer profileNamed customers7 records
Segments7 records
Ideal customer profiles4 records
Renue Wellness technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Renue Wellness partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Clinics and Practice Owners (Expansion Program)coreRenue Wellness is actively seeking partnership with clinics focused on mental health, chronic pain, or integrative wellness, providers offering or interested in ketamine/psychedelic therapies, founders seeking operational support or succession planning, and practices ready to scale. Partnership models include mergers, full acquisitions, co-branded affiliations, and support for clinic transitions.
Scale indicators3 records
Recent moves9 records
Expansion highlights5 records
Renue Wellness competitors and assessment
Company assessmentBroad incumbents
- Talkiatry: National online psychiatry practice treating depression, anxiety, PTSD, and related conditions with insurance-accepting psychiatrists. Overlaps with Renue's patient base for first-line psychiatric care before patients escalate to interventional options.
- Cerebral: Large telehealth mental health provider offering online psychiatry, medication management, and treatment for depression and anxiety. Indirect competitor for the same patient demand pool but competing via remote care and prescriptions rather than in-clinic ketamine/TMS.
- New Vista Behavioral Health: Broader behavioral health platform operating outpatient and residential mental health programs, including ketamine-assisted services. Larger incumbent with overlapping interventional psychiatry offerings and broader payer reach than Renue.
Direct peers
- Klarisana: Outpatient ketamine infusion clinics (originally Texas-based, now expanding regionally) focused on treatment-resistant depression, PTSD, and chronic pain. Closely comparable to Renue as a multi-site ketamine therapy practice serving similar patient populations with self-pay and insurance-reimbursable offerings.
- Stella Mental Health: Outpatient interventional psychiatry clinics offering ketamine infusion therapy, Spravato, and TMS for depression, anxiety, PTSD, and OCD. Directly comparable specialty outpatient model with multi-state expansion similar to Renue's footprint strategy.
- Greenbrook TMS NeuroHealth Centers: Large outpatient network of TMS therapy centers treating depression, anxiety, and OCD. Competes with Renue's TMS offering and shares the same specialty outpatient psychiatry / interventional treatment model targeting treatment-resistant patients.
- Better U (Ketamine Clinics): Multi-location outpatient ketamine and Spravato clinic operator in the U.S. with a similar focus on treatment-resistant depression, anxiety, and chronic pain. Comparable treatment menus, self-pay + insurance mix, and multi-site growth strategy.
- Actify Neurotherapy Centers: Multi-location outpatient mental health clinic chain offering IV ketamine, Spravato, and TMS for treatment-resistant depression, anxiety, PTSD, and similar indications — essentially the same business model and treatment modalities as Renue Wellness, just larger and more geographically dispersed.
Others
- LegitScript: Third-party healthcare legitimacy and compliance certification provider — not a clinical peer, but Renue displays a LegitScript certification badge to build trust with consumers searching for ketamine therapy online, making LegitScript an enabling ecosystem partner.
Emerging players
- Mindbloom: Direct-to-consumer at-home ketamine therapy platform serving treatment-resistant depression and anxiety in multiple U.S. states. Comparable patient population and indications, but competing via telehealth/at-home delivery rather than in-clinic infusion.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Renue Wellness social profiles
Digital presenceRenue Wellness compliance and trust
Trust signalCompliance3 records
Renue Wellness financial estimates
Financial estimateRevenue estimate
Valuation estimate
Renue Wellness leadership team
Management profileNumber of profiles
Profiles3 records
Renue Wellness funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Renue Wellness M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Renue Wellness
What does Renue Wellness do?
Renue Wellness is a multi-location mental health practice delivering medically supervised IV ketamine infusion therapy, FDA-approved Spravato (esketamine) treatment, Ketamine-Assisted Psychotherapy, and TMS therapy to adults with treatment-resistant depression, anxiety, PTSD, OCD, suicidal ideation, postpartum depression, and chronic pain. Services are delivered through clinics in New Hyde Park NY, Paramus NJ, and Crestview FL, supported by provider referrals and insurance billing.
Is Renue Wellness a public or private company?
Renue Wellness is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Renue Wellness founded?
Renue Wellness was founded in 2017. It employs 1 to 10 people.
Where is Renue Wellness based?
Renue Wellness is headquartered in New Hyde Park, New York, United States, in the North America region.
How does Renue Wellness make money?
Four revenue lines are on record. IV Ketamine Infusion Therapy is the primary driver. The others are spravato (Esketamine) Treatment, TMS Therapy and ketamine-Assisted Psychotherapy.
Who are Renue Wellness's main competitors?
Broad incumbents on record are Talkiatry, Cerebral and New Vista Behavioral Health. Direct peers are Klarisana, Stella Mental Health, Greenbrook TMS NeuroHealth Centers, Better U (Ketamine Clinics) and Actify Neurotherapy Centers. LegitScript is listed as an others. Mindbloom is listed as an emerging player.
Does Renue Wellness have an API?
No public API is recorded for Renue Wellness.
What industry is Renue Wellness in?
Renue Wellness's product category is Mental Health Treatment Services. Its primary akta.pro industry code is HLAFABAD, Outpatient Substance Use Disorder (SUD) Treatment Programs. Its NAICS code is 621420 and its SIC code is 8093.